Author

T. R. Kislinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 4 Organism:human· 4 Approach:statistical model· 4 Research Focus:cell type annotation· 3 Research Focus:clustering· 2 Research Focus:gene regulatory network inference· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

A. Macklin· 2 shared K. Aliar· 2 shared R. Khokha· 2 shared A. Devisme· 1 shared A. E. Casey· 1 shared A. Khoo· 1 shared A. Mansouri· 1 shared A. Nixon· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Macklin

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma

M. A. Qazi, S. K. Salim, K. R. Brown, N. Mikolajewicz, N. Savage, H. Han, M. K. Subapanditha, D. Bakhshinyan, A. Nixon, P. Vora, K. Desmond, C. Chokshi, M. Singh, A. Khoo, A. Macklin, , S. K. Singh

This study characterizes the minimal residual disease state in glioblastoma, revealing distinct evolutionary trajectories and immunomodulatory signatures associated with recurrence.

bioRxiv · Jan 28, 2022Cancer Biology

Spatially confined sub-tumor microenvironments orchestrate pancreatic cancer pathobiology

B. T. Grünwald, A. Devisme, G. Andrieux, F. Vyas, K. Aliar, C. W. McCloskey, A. Macklin, G. H. Jang, R. Denroche, J. M. Romero, P. Bavi, P. Bronsert, F. Notta, G. O'Kane, J. Wilson, , R. Khokha

This study identifies spatially confined sub-tumor microenvironments in PDAC that drive distinct tumor progression outcomes.

bioRxiv · Feb 18, 2021Cancer Biology

Quantifying the Influence of Mutation Detection on Tumour Subclonal Reconstruction

L. Y. Liu, V. Bhandari, A. Salcedo, S. M. Espiritu, Q. D. Morris, T. R. Kislinger, P. C. Boutros

This study evaluates subclonal reconstruction pipelines for prostate cancer, showing significant variability and biases in predicting subclonal architecture and mutation timing.

Nature Communications · Dec 7, 2020Peer-reviewedCancer Biology

Mammary epithelial cells have lineage-restricted metabolic identities

M. Mahendralingam, K. Aliar, A. E. Casey, D. Pellacani, H. Kim, V. Ignatchenko, M. G. Valero, L. Palomero, A. Sinha, V. Stambolic, M. Alam, A. Schimmer, H. Berman, M. A. Pujana, C. J. Eaves, , R. Khokha

The paper identifies lineage-restricted metabolic identities in normal mammary epithelial cells and links them to breast cancer metabolic heterogeneity.

bioRxiv · Oct 8, 2019Cell Biology